These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15537383)

  • 1. The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells.
    Wilson S; Greer B; Hooper J; Zijlstra A; Walker B; Quigley J; Hawthorne S
    Biochem J; 2005 Jun; 388(Pt 3):967-72. PubMed ID: 15537383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs). KLK4 and PAR-2 are co-expressed during prostate cancer progression.
    Ramsay AJ; Dong Y; Hunt ML; Linn M; Samaratunga H; Clements JA; Hooper JD
    J Biol Chem; 2008 May; 283(18):12293-304. PubMed ID: 18308730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolytic activation of the protease-activated receptor (PAR)-2 by the glycosylphosphatidylinositol-anchored serine protease testisin.
    Driesbaugh KH; Buzza MS; Martin EW; Conway GD; Kao JP; Antalis TM
    J Biol Chem; 2015 Feb; 290(6):3529-41. PubMed ID: 25519908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAR-2 activation regulates IL-8 and GRO-alpha synthesis by NF-kappaB, but not RANTES, IL-6, eotaxin or TARC expression in nasal epithelium.
    Rudack C; Steinhoff M; Mooren F; Buddenkotte J; Becker K; von Eiff C; Sachse F
    Clin Exp Allergy; 2007 Jul; 37(7):1009-22. PubMed ID: 17581194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells.
    Chen YW; Lee MS; Lucht A; Chou FP; Huang W; Havighurst TC; Kim K; Wang JK; Antalis TM; Johnson MD; Lin CY
    Am J Pathol; 2010 Jun; 176(6):2986-96. PubMed ID: 20382709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.
    Mize GJ; Wang W; Takayama TK
    Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue.
    Takeuchi T; Shuman MA; Craik CS
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11054-61. PubMed ID: 10500122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma.
    Lucas JM; True L; Hawley S; Matsumura M; Morrissey C; Vessella R; Nelson PS
    J Pathol; 2008 Jun; 215(2):118-25. PubMed ID: 18338334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia.
    Afar DE; Vivanco I; Hubert RS; Kuo J; Chen E; Saffran DC; Raitano AB; Jakobovits A
    Cancer Res; 2001 Feb; 61(4):1686-92. PubMed ID: 11245484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis.
    Lucas JM; Heinlein C; Kim T; Hernandez SA; Malik MS; True LD; Morrissey C; Corey E; Montgomery B; Mostaghel E; Clegg N; Coleman I; Brown CM; Schneider EL; Craik C; Simon JA; Bedalov A; Nelson PS
    Cancer Discov; 2014 Nov; 4(11):1310-25. PubMed ID: 25122198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of TMPRSS2 by HAI-2 reduces prostate cancer cell invasion and metastasis.
    Ko CJ; Hsu TW; Wu SR; Lan SW; Hsiao TF; Lin HY; Lin HH; Tu HF; Lee CF; Huang CC; Chen MM; Hsiao PW; Huang HP; Lee MS
    Oncogene; 2020 Sep; 39(37):5950-5963. PubMed ID: 32778768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen-Induced TMPRSS2 Activates Matriptase and Promotes Extracellular Matrix Degradation, Prostate Cancer Cell Invasion, Tumor Growth, and Metastasis.
    Ko CJ; Huang CC; Lin HY; Juan CP; Lan SW; Shyu HY; Wu SR; Hsiao PW; Huang HP; Shun CT; Lee MS
    Cancer Res; 2015 Jul; 75(14):2949-60. PubMed ID: 26018085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane-type serine protease-1/matriptase induces interleukin-6 and -8 in endothelial cells by activation of protease-activated receptor-2: potential implications in atherosclerosis.
    Seitz I; Hess S; Schulz H; Eckl R; Busch G; Montens HP; Brandl R; Seidl S; Schömig A; Ott I
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):769-75. PubMed ID: 17255532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Basis of Covalent Inhibitory Mechanism of TMPRSS2-Related Serine Proteases by Camostat.
    Sun G; Sui Y; Zhou Y; Ya J; Yuan C; Jiang L; Huang M
    J Virol; 2021 Sep; 95(19):e0086121. PubMed ID: 34160253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prostate cancer TMPRSS2:ERG fusion synergizes with the vitamin D receptor (VDR) to induce CYP24A1 expression-limiting VDR signaling.
    Kim JS; Roberts JM; Bingman WE; Shao L; Wang J; Ittmann MM; Weigel NL
    Endocrinology; 2014 Sep; 155(9):3262-73. PubMed ID: 24926821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro characterization of TMPRSS2 inhibition in IPEC-J2 cells.
    Pászti-Gere E; Czimmermann E; Ujhelyi G; Balla P; Maiwald A; Steinmetzer T
    J Enzyme Inhib Med Chem; 2016; 31(sup2):123-129. PubMed ID: 27277342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic analysis of mice lacking the Tmprss2-encoded protease.
    Kim TS; Heinlein C; Hackman RC; Nelson PS
    Mol Cell Biol; 2006 Feb; 26(3):965-75. PubMed ID: 16428450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of protease-activated receptors-1,-2, and-4 (PAR-1, -2, and -4) in prostate cancer.
    Black PC; Mize GJ; Karlin P; Greenberg DL; Hawley SJ; True LD; Vessella RL; Takayama TK
    Prostate; 2007 May; 67(7):743-56. PubMed ID: 17373694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostasin regulates iNOS and cyclin D1 expression by modulating protease-activated receptor-2 signaling in prostate epithelial cells.
    Chen LM; Hatfield ML; Fu YY; Chai KX
    Prostate; 2009 Dec; 69(16):1790-801. PubMed ID: 19670249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TMPRSS2, a novel membrane-anchored mediator in cancer pain.
    Lam DK; Dang D; Flynn AN; Hardt M; Schmidt BL
    Pain; 2015 May; 156(5):923-930. PubMed ID: 25734995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.